Nimotuzumab
- Generic Name
- Nimotuzumab
- Drug Type
- Biotech
- CAS Number
- 780758-10-3
- Unique Ingredient Identifier
- 6NS400BXKH
Overview
No overview information available.
Background
No background information available.
Indication
Investigated for use/treatment in head and neck cancer, brain cancer, pediatric indications, pancreatic cancer, lung cancer, and colorectal cancer.
Associated Conditions
- Advanced Head and Neck Cancer
- Advanced Stage Head and Neck Cancer
- Glioblastoma Multiforme (GBM)
- High Grade Glioma (HGG)
- Advanced Epithelial Tumor of the Head and Neck
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath